2025 Year in Review: Health Systems Sought to Prioritize Artificial Intelligence Use Cases
Among the initial pain points addressed were ambient clinical documentation and coding and billing automation
Among the initial pain points addressed were ambient clinical documentation and coding and billing automation
Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year. The post Hospital M&A…
During two House hearings, health insurance CEOs were questioned on rising healthcare costs, vertical integration and prior authorization. The post Lawmakers Grill Health Insurance CEOs: 4 Key Takeaways appeared first on MedCity News.
This page holds an archive of KFF’s regular surveys of states about their Medicaid home- and community-based services (HCBS) programs and their eligibility policies for people who are eligible for Medicaid on the basis of having a disability or being ages 65 and older (the “non-MAGI” eligibility pathways).
In 2024, ACA enrollment (including Marketplace, Medicaid expansion, and BHP) reached 44 million, or 16.4% of the nonelderly U.S. population. From 2020-2024, enrollment in ACA coverage increased by over 60%.
Congress released a stopgap funding bill with a significant healthcare package, and provider groups are reacting favorably. They are mainly applauding provisions that reign in PBMs’ business practices, extend telehealth flexibilities, and boost payments to hospitals and physicians. The post How Did Provider Groups React to Congress’ End-of-Year Healthcare Package? appeared first on MedCity News.
Over the past 15 years, financial and administrative barriers – most notably step therapy mandates and prior authorization requirements – have repeatedly forced patients through suboptimal or ineffective treatments before they can try another therapy, have tied the hands of healthcare professionals and patients alike. Now there’s a possible solution. The post Join the Fight…
The Series B extension brings Atavistik Bio’s Series B financing to $160 million. The startup’s lead program is in development for hereditary hemorrhagic telangiectasia (HHT), an inherited bleeding disorder. The post Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies appeared first on MedCity News.
CMO Jeffrey Giullian, M.D., M.B.A., describes how DaVita is using machine learning to improve outcomes for those receiving dialysis at home
Joey Ballard is an internal medicine resident at the University of Illinois-Chicago. He wrote to “An Arm and a Leg” about a resolution the American Medical Association recently adopted calling on hospitals to do more to make sure patients who qualify for charity care get it. And that legislators and regulators make sure that’s happening….